Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications
Pharmaceutics · 11.06.2023 · 15 (6) · 1708
DOI: 10.3390/pharmaceutics15061708 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 11.06.2023. Verfasst von Si Gou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, University of Geneva, 1211 Geneva, Switzerland. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innosuisse - Swiss Innovation Agency, Swiss Innovation Agency.
Abstract (Originalsprache)
Most marketed HA-based dermal fillers use chemical cross-linking to improve mechanical properties and extend their lifetime in vivo; however, stiffer products with higher elasticity require an increased extrusion force for injection in clinical practice. To balance longevity and injectability, we propose a thermosensitive dermal filler, injectable as a low viscosity fluid that undergoes gelation in situ upon injection. To this end, HA was conjugated via a linker to poly(N-isopropylacrylamide) (pNIPAM), a thermosensitive polymer using “green chemistry”, with water as the solvent. HA-L-pNIPAM hydrogels showed a comparatively low viscosity (G′ was 105.1 and 233 for Candidate1 and Belotero Volume®, respectively) at room temperature and spontaneously formed a stiffer gel with submicron structure at body temperature. Hydrogel formulations exhibited superior resistance against enzymatic and oxidative degradation and could be administered using a comparatively lower injection force (49 N and >100 N for Candidate 1 and Belotero Volume®, respectively) with a 32G needle. Formulations were biocompatible (viability of L929 mouse fibroblasts was >100% and ~85% for HA-L-pNIPAM hydrogel aqueous extract and their degradation product, respectively), and offered an extended residence time (up to 72 h) at the injection site. This property could potentially be exploited to develop sustained release drug delivery systems for the management of dermatologic and systemic disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, University of Geneva, 1211 Geneva, Switzerland.
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1211 Geneva, Switzerland.
- KYLYS Sàrl, 34, Route de la Galaise, c/o FONGIT, Plan-les-Ouates, 1228 Geneva, Switzerland.
- Clinique Internationale de Dermatologie Genève SA, 1201 Geneva, Switzerland.
- Private Practice, 8, Chemin de la Fontaine, Chêne-Bougeries, 1224 Geneva, Switzerland.
ORCID-Profile: Alexandre Porcello, Olivier Jordan, Yogeshvar N Kalia
Förderung
- Innosuisse - Swiss Innovation Agency
- Swiss Innovation Agency
Zitieren
APA
Gou, S., Porcello, A., Allémann, E., Salomon, D., Micheels, P., Jordan, O., & Kalia, Y. N. (2023). Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications. Pharmaceutics, 15(6), 1708. https://doi.org/10.3390/pharmaceutics15061708
Vancouver
Gou S, Porcello A, Allémann E, Salomon D, Micheels P, Jordan O, et al. Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications. Pharmaceutics. 2023;15(6):1708. doi:10.3390/pharmaceutics15061708
BibTeX
@article{Gou2023,
author = {Gou, Si and Porcello, Alexandre and Allémann, Eric and Salomon, Denis and Micheels, Patrick and Jordan, Olivier and Kalia, Yogeshvar N},
title = {Injectable Hyaluronan-Based Thermoresponsive Hydrogels for Dermatological Applications},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {6},
pages = {1708},
doi = {10.3390/pharmaceutics15061708}
}
EUVIMED